📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Buruli-RifDACC: Evaluation of the efficacy and cost-effectiveness of high-dose versus standard-dose rifampicin on outcomes in Mycobacteriumulcerans disease, a protocol for a randomised controlled trial in Ghana. (2022)

First Author: Amoako YA

Attributed to: R Phillips, KNUST Ghana. Pathogenesis and management of M. ulcerans disease, Buruli ulcer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3310/nihropenres.13332.1

PubMed Identifier: 36825217

Publication URI: http://europepmc.org/abstract/MED/36825217

Type: Journal Article/Review

Volume: 2

Parent Publication: NIHR open research

ISSN: 2633-4402